Stryker Corporation (SYK)

NYSE: SYK · Real-Time Price · USD

339.98

+8.61 (2.60%)

At close: Aug 19, 2026, 8:00 PM

2.60% (1D)

No data available

Bid	340.36
Market Cap	130.41B
Revenue (ttm)	25.84B
Net Income (ttm)	3.73B
Beta	0.77
EPS (ttm)	9.64
PE Ratio (ttm)	35.27
Forward PE	20.28
P/B (ttm)	5.67
P/S (ttm)	5.05
Earnings Date	Oct 29, 2026

Ask	339.9
Volume	1,778,415
Avg. Volume (20D)	2,592,835
Open	331.74
Previous Close	331.37
Day's Range	331.00 - 343.90
52-Week Range	281.00 - 396.86
Analyst	n/a
Price Target	n/a
Dividends	$3.52 (1.06%)
Ex-Dividend Date	Sep 30, 2026

About SYK

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical co...

[Read more]

Industry Medical Devices

Sector Healthcare

IPO Date Mar 17, 1980

Employees 56,000

Stock Exchange NYSE

Ticker Symbol SYK

Website https://www.stryker.com

Full Company Profile

Financial Performance

In 2025, Stryker's revenue was 25.12B, an increase of 11.16% compared to the previous year's 22.59B. Earnings were 3.25B, an increase of 8.45%.

Financial Statements

Earnings Surprise

Stryker has released their quarterly earnings on Jul 30, 2026:

Revenue of $6.59B misses estimates by $0, with 9.42% YoY growth.

EPS of 3.69 exceeds estimates by 0.20, with 17.89% YoY growth.

Next Earnings Release

Stryker Corporation is scheduled to release its earnings on Oct 29, 2026, after market closes.
Analysts project revenue of ... Upgrade

News

13 hours ago · StockStory

Why Stryker (SYK) Stock Is Trading Up Today

Shares of medical technology company Stryker (NYSE:SYK) jumped 2.7% in the afternoon session after its Stryker Sales unit in Michigan won a $100 million contract modification from the US Defense Logis...

20 hours ago · Zacks

Is IART Still Attractive as Its Low Valuation Meets Execution Risks?

Integra's steep valuation discount meets margin gains and cost savings, but modest growth, leverage and unresolved FDA risks keep execution in focus.

1 day ago · MarketBeat

Mercury Systems Q4 Earnings Call Highlights

Mercury Systems (NASDAQ:MRCY) reported record fourth-quarter bookings, backlog and revenue for fiscal 2026, as the defense technology company cited broad demand across its portfolio and raised its lon...